A federal watchdog report has found that nursing homes continue to use antipsychotics as chemical restraints, sometimes without first attempting required non-drug interventions, and national data show antipsychotic use among adults aged 65 and older rose nearly 52% between 2015 and 2024, with long-term use up almost 65%. The findings matter because they suggest a decade of federal efforts to curb the practice has not reversed a trend that carries documented risks of death and serious harm for frail older adults.
The Citizens Commission on Human Rights (CCHR) International is demanding greatly increased oversight of the drugging of the elderly and of electroshock treatment, a practice the group says should be prohibited. The recommendations follow a federal assessment that antipsychotic use among nursing home residents remains concerning despite a decade of reduction efforts.
The implications are significant for residents with dementia. The Food and Drug Administration issued a boxed warning against antipsychotic use in this population because of an increased risk of death, and studies link newer antipsychotics in older adults with dementia to sharply higher risks of stroke, heart failure, accelerated cognitive decline, and bone fractures from falls. The Health and Human Services Office of Inspector General has flagged the drugs' sedative effect, raising concerns that nursing homes may use them to control residents' behavior for the benefit of staff. Investigators found some medical directors failed to prevent inappropriate use, pharmacists did not identify medical concerns or recommend dose reductions, and inadequate policies undermined safeguards meant to protect residents.
Lori Smetanka, executive director of the National Consumer Voice for Quality Long-Term Care, described the human cost: "Instead of getting to the root problem and addressing the problem, we're quieting them down. And then that's what leads to significant problems with their health and well-being."
The risk extends to electroconvulsive therapy, or electroshock, which passes up to 460 volts of electricity through the brain to induce a grand-mal seizure. Medicare data show more than 125,500 ECT sessions in 2014 alone and 20,436 beneficiaries receiving nearly 116,000 treatments in 2018, with $31 million paid for the 2016–2018 period. A clinical neuropsychology study of 62 non-demented elderly depressed patients found 40% showed significant individual-level decline within one week after ECT. A 1993 Brown University study of patients 80 and older found 27% of those given ECT were dead within one year compared with 4% of a similar untreated group, and at two years the figures were 46% versus 10%, as reported by http://usatoday30.usatoday.com/life/health/lhs195.htm.
Jan Eastgate, president of CCHR International, said the cumulative picture is one of institutionalization that too often relies on drugs, ECT, and restraints rather than addressing root causes, calling it "the legacy of the widespread introduction of psychiatric treatment into the care of the elderly" and urging intense oversight, an end to forced psychiatric treatment, and adoption of safer alternatives. CCHR encourages reporting psychiatric abuse of the elderly and advises contacting Congressional and state representatives to demand strict enforcement of non-drug interventions and a prohibition on electroshock for all. The group has previously urged oversight of elderly patients being electroshocked, as detailed in its https://www.cchrint.org/2021/05/17/cchr-urges-mental-health-month-oversight-of-elderly-being-electroshocked/.


